ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,675Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 559

$501K Total Retail Price of All Prescriptions

Rank: 31 out of 559

539 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 556 510 1 1
LEVOTHYROXINE SODIUM 533 481 2 2
SIMVASTATIN 512 440 3 3
OMEPRAZOLE 417 325 4 4
METFORMIN HCL 352 296 5 5
AMLODIPINE BESYLATE 315 265 6 6
HYDROCODONE-ACETAMINOPHEN 296 236 S3 7 7
GABAPENTIN 233 186 8 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 232 214 9 18
ALENDRONATE SODIUM 204 195 10 13
DOXAZOSIN MESYLATE 174 164 11 43
LOVASTATIN 163 163 12 10
SERTRALINE HCL 154 149 13 19
DONEPEZIL HCL 150 150 14 36
GLIPIZIDE 137 117 15 31
FLUTICASONE PROPIONATE 136 113 16 22
ATENOLOL 133 117 17 15
ALLOPURINOL 128 128 18 34
TAMSULOSIN HCL 126 114 19 25
LOSARTAN POTASSIUM 121 96 20 14
METOPROLOL TARTRATE 120 111 21 12
METOPROLOL SUCCINATE 115 92 22 16
RANITIDINE HCL 113 89 23 26
TRAZODONE HCL 110 86 24 28
HYDROCHLOROTHIAZIDE 107 95 25 8
NAMENDA 102 102 26 56
WARFARIN SODIUM 102 102 26 24
JANUVIA 100 68 28 50
FUROSEMIDE 95 84 29 11
ATORVASTATIN CALCIUM 95 91 29 20
ADVAIR DISKUS 93 81 31 46
PAROXETINE HCL 92 63 32 48
PRAVASTATIN SODIUM 90 74 33 35
TRAMADOL HCL 87 72 34 27
ZOLPIDEM TARTRATE 86 66 35 17
VENLAFAXINE HCL ER 86 63 35 111
LANTUS 85 61 37 40
MELOXICAM 83 62 38 42
PROAIR HFA 82 75 39 29
TRIAMTERENE-HCTZ 82 75 39 47
TRIAMCINOLONE ACETONIDE 81 62 41 84
CRESTOR 80 56 42 33
MIRTAZAPINE 74 73 43 61
CHLORTHALIDONE 69 47 44 100
GLIPIZIDE ER 67 51 45 77
IBUPROFEN 65 31 46 30
FELODIPINE ER 65 60 46 72
OXYCODONE HCL 63 18 S2 48 32
ENDOCET 60 46 S2 49 105
ESCITALOPRAM OXALATE 59 48 50 109
ACTOS 57 45 51 87
FENOFIBRATE 55 26 52 69
PHENYTOIN SODIUM EXTENDED 53 29 53 123
CARVEDILOL 52 49 54 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.